Skip to main content
SpringerLink
Log in

Discriminant validity of the Medical Outcomes Study cognitive function scale in HIV disease patients

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Human immunodeficiency virus (HIV) infection results in a chronic course of disease progression and eventual death. With this disease progression comes decreases in health-related quality of life and cognitive function in many patients. We evaluated the construct and discriminant validity of the Medical Outcomes Study four-item and six-item cognitive function scale in a sample of 162 patients with HIV disease. The patients were assessed at baseline and after 4 months with the cognitive function scale, a cognitive functioning transition item, the Reitan trail making test (TMT) and the Centers for Epidemiologic Studies Depression (CES-D) scale. The results found that the four- and six-item cognitive function scales varied by HIV disease stage, CD4 count, self-reported change in cognitive function, TMT-based cognitive impairment and depression. The differences in the cognitive function scores were attenuated, but still remained statistically significant even after controlling for depression. The cognitive function scales predict cognitive impairment based on the TMT. The results support the construct validity of these self-report cognitive function scales.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Burgess A, Catalan J, Deyer M, Hawkins D, Gazzard B. The reliability and validity of two HIV-specific health-related quality of life measures. AIDS 1993; 7: 1001-1008.

    Google Scholar 

  2. Lubeck DP, Fries JF. Health status among persons infected with human immunodeficiency virus: a community-based study. Med Care 1993; 31: 269-276.

    Google Scholar 

  3. Lubeck DP, Fries JF. Changes in quality of life among persons with HIV infection. Qual Life Res 1992; 1: 359-366.

    Google Scholar 

  4. Bornstein RA, Nasrallah HA, Para MF, Whitacre CC, Rosenberger P, Fass RJ. Neuropsychological performance in symptomatic and asymptomatic HIV infection. AIDS 1993; 7: 519-524.

    Google Scholar 

  5. Bornstein RA, Nasrallah HA, Para MF, Whitacre CC, Fass RJ. Change in neuropsychological performance in asymptomatic HIV infection: 1-year follow-up. AIDS 1993; 7: 1607-1611.

    Google Scholar 

  6. Egan V, Brettle RP, Goodwin GM. The Edinburgh cohort of HIV-positive drug users: pattern of cognitive impairment in relation to progression of disease. Br J Psychiatr 1992; 161: 522-531.

    Google Scholar 

  7. Boccellari AA, Dilly JW, Chambers DB et al. Immune function and neuropsychological performance in HIV-1-infected homosexual men. J AIDS 1993; 6: 592-601.

    Google Scholar 

  8. Maruff P, Currie J, Malone V, McArthur-Jackson C, Mulhall B, Benson E. Neuropsychological characterization of the AIDS dementia complex and rationalization of a test battery. Arch Neurol 1994; 51: 689-695.

    Google Scholar 

  9. McAllister RH, Herns MV, Harrison MJG et al. Neurological and neuropsychological performance in HIV seropositive men without symptoms. J Neurol Neurosurg Psychiatr 1992; 55: 143-148.

    Google Scholar 

  10. Bozzette SA, Hays RD, Berry SH, Kanouse DE. A perceived health index for use in persons with advanced HIV disease: derivation, reliability and validity. Med Care 1994; 32: 716-731.

    Google Scholar 

  11. Adams KM, Heaton RK. Statement concerning the NIMH neuropsychological battery. J Clin Exp Neuropsych 1990; 12: 960-962.

    Google Scholar 

  12. Butters N, Grant I, Haxby J et al. Assessment of AIDS-related cognitive changes: recommendations of the NIMH workshop on neuropsychological assessment approaches. J Clin Exper Neuropsychol 1990; 12: 963-978.

    Google Scholar 

  13. Folstein MF, Folstein SE, McHugh PR. Mini Mental State, a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.

    Google Scholar 

  14. Power C, Selnes OA, Grim JA, McArthur JC. HIV dementia scale: a rapid screening test. AIDS 1995; 8: 273-278.

    Google Scholar 

  15. Jones BN, Teng EL, Folstein MF, Harrison KS. A new bedside test of cognition for patients with HIV infection. Ann Intern Med 1993; 119: 1001-1004.

    Google Scholar 

  16. Van Gorpet W, Miller E, Satz P, Visscher B. Neuropsychological performance in HIV-1 immunocompromised patients. Int Conf AIDS 1989; 5: 464.

    Google Scholar 

  17. Dilley JW, Boccellari A, Davis A. The use of the Mini Mental Status Exam as a cognitive screen in patients with AIDS. Int Conf AIDS 1989; 5: 384.

    Google Scholar 

  18. Wu AW, Rubin HR, Mathews WC et al. A health status questionnaire using 30 items from the Medical Outcomes Study: preliminary validation in persons with early HIV infection. Med Care 1991; 29: 786-798.

    Google Scholar 

  19. Stewart AL, Ware JE, Sherbourne CD, Wells KB. Psychological distress/well-being and cognitive functioning measures. In: Stewart AL, Ware JE, eds. Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Durham, NC: Duke University, 1992: 102-142.

    Google Scholar 

  20. Revicki DA, Wu AW, Murray MI. Change in clinical status, health status, and health utility outcomes in HIV-infected patients. Med Care 1995; 33: AS173-AS182.

    Google Scholar 

  21. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measurement 1977; 1: 385-401.

    Google Scholar 

  22. Reitan RM. Trail Making Test: Manual for Administration and Scoring. Tucson, AZ: Reitan Neuropsychology Laboratory, 1992.

    Google Scholar 

  23. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: New England Medical Center, The Health Institute, 1993.

    Google Scholar 

  24. Joseph JG, Caumartin SM, Tal M et al. Psychological functioning in a cohort of gay men at risk for AIDS: a three year descriptive study. J Nerv Mental Dis 1990; 178: 607-615.

    Google Scholar 

  25. Murphy JM. Psychiatric Instrument Development for Primary Care Research: Patient Self-report Questionnaires. Boston, MA: Department of Psychiatry, Harvard Medical School, 1982.

    Google Scholar 

  26. Mitchell JE, Marshall DW, Goethe E, Leger D, Boswell RN. Human immunodeficiency virus (HIV): immune system compromise and neuropsychological functioning. Neurology 1989; 39(suppl): 129-133.

    Google Scholar 

  27. Bornstein RA, Nasrallah HA, Para MF, Fass RJ, Whitacre CC, Rice RR. Rate of CD4 decline and neuropsychological performance in HIV infection. Arch Neurol 1991; 48: 704-707.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MEDTAP International, Inc, BethesdaMD, USA

    D. A. Revicki & K. Chan

  2. PCS Health Systems, Inc, Phoenix, AZ, USA

    F. Gevirtz

Authors
  1. D. A. Revicki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Gevirtz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Revicki, D.A., Chan, K. & Gevirtz, F. Discriminant validity of the Medical Outcomes Study cognitive function scale in HIV disease patients. Qual Life Res 7, 551–559 (1998). https://doi.org/10.1023/A:1008866122441

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1008866122441

Search

Navigation